Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin in patients at high risk of melanoma
NCT00462280Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2007
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lovastatin in melanoma, sponsored by National Cancer Institute. Started May 2007; status: completed.
02
Drugs
lovastatin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00462280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00462280.